Biotech startup uses nanoparticles to induce immune tolerance
| Date | 23rd, May 2019 |
|---|---|
| Source | MIT News - Organizations and Universities Websites |
DESCRIPTION
Selecta Bioscience’s ImmTOR platform could improve gene therapies and prevent some drug side effects.